Rationale for the use of GLP-1Receptor agonists in COPD

Oscar M P Jolobe, MB., ChB; Rationale for the use of GLP-1Receptor agonists in COPD, QJM: An International Journal of Medicine, , hcag252, https://doi.org/

Authors

Publication Details

Journal
QJM
Published
2026-09-17
DOI
https://doi.org/10.1093/qjmed/hcag252
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Rationale for the use of GLP-1Receptor agonists in COPD

Oscar M P Jolobe
QJM
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Rationale for the use of GLP-1Receptor agonists in COPD

Oscar M P Jolobe
article en

Abstract

Oscar M P Jolobe, MB., ChB; Rationale for the use of GLP-1Receptor agonists in COPD, QJM: An International Journal of Medicine, , hcag252, https://doi.org/

QJM
Openalex Percentile: Top 11%
Chronic Obstructive Pulmonary Disease (COPD) Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Rationale for the use of GLP-1Receptor agonists in COPD — Oscar M P Jolobe · QJM (2026) | TGRS Research Map | TGRS